Why Biogen Stock Sank While the Market Soared on Thursday
Bullishness was in the air on the stock market on Tuesday, but you’d hardly know that from the performance of Biogen (NASDAQ: BIIB). The healthcare sector mainstay saw its share price slump by over 2% that trading session, in contrast to the gravity-defying S&P 500 index’s nearly 3% increase. Investors were clearly unimpressed with the…